Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway

Molecular Medicine Reports

Volumn 13, Issue 2, 2016, Pages 1827-1832

  Gao, Hui ^a   Wang, Jianrong ^a  

^a Dongying People's Hospital of Shandong Province   (China)

Author keywords

Andrographolide; Multiple myeloma; Nuclear factor B; Toll like receptor 4

Indexed keywords

ANDROGRAPHOLIDE; CASPASE 3; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; DITERPENE; TLR4 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; MULTIPLE MYELOMA CELL LINE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; ENZYME ACTIVATION; HUMANS; MULTIPLE MYELOMA; NF-KAPPA B; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84956870484     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4703     Document Type: Article

References (29)

1. Auner HW, Szydlo R, Hoek J, Goldschmidt H, Stoppa AM, Morgan GJ, Moreau P, Attal M, Marit G, Russell N, et al: Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years. Bone Marrow Transplant 50: 209-215, 2015.
2. Peng J, Chen Y, Lin J, Zhuang Q, Xu W, Hong Z and Sferra TJ: Patrinia scabiosaefolia extract suppresses proliferation and promotes apoptosis by inhibiting the STAT3 pathway in human multiple myeloma cells. Mol Med Rep 4: 313-318, 2011.
3. Li H, Xu H and Sun B: Lipopolysaccharide regulates MMP.9 expression through TLR4/NFκB signaling in human arterial smooth muscle cells. Mol Med Rep 6: 774-778, 2012.
4. Wang AC, Ma YB, Wu FX, Ma ZF, Liu NF, Gao R, Gao YS and Sheng XG: TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88.positive human ovarian carcinoma in vitro. Oncol Lett 7: 871-877, 2014.
5. Murray MY, Zaitseva L, Auger MJ, Craig JI, MacEwan DJ, Rushworth SA and Bowles KM: Ibrutinib inhibits BTK-driven NFκB p65 activity to overcome bortezomib-resistance in multiple myeloma. Cell Cycle 14: 2367-2375, 2015.
6. Dou A, Wang Z, Zhao J, Liu J and Zheng C: Identification of therapeutic target genes with DNA microarray in multiple myeloma cell line treated by IKKβ/NFκB inhibitor. Acta Cir Bras 29: 696-702, 2014.
7. Serrano FG, Tapia-Rojas C, Carvajal FJ, Hancke J, Cerpa W and Inestrosa NC: Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS.1 mice. Mol Neurodegener 9: 61, 2014.
8. Chua LS: Review on liver inflammation and antiinflammatory activity of Andrographis paniculata for hepatoprotection. Phytother Res 28: 1589-1598, 2014.
9. Yang D, Zhang W, Song L and Guo F: Andrographolide protects against cigarette smoke-induced lung inflammation through activation of heme oxygenase-1. J Biochem Mol Toxicol 27: 259-265, 2013.
10. Zeng X, Liu X, Bian J, Pei G, Dai H, Polyak SW, Song F, Ma L, Wang Y and Zhang L: Synergistic effect of 14.alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa. Antimicrob Agents Chemother 55: 3015-3017, 2011.
11. Lee JC, Tseng CK, Young KC, Sun HY, Wang SW, Chen WC, Lin CK and Wu YH: Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Br J Pharmacol 171: 237-252, 2014.
12. Lee C, Oh JI, Park J, Choi JH, Bae EK, Lee HJ, Jung WJ, Lee DS, Ahn KS and Yoon SS: TNF α mediated IL-6 secretion is regulated by JAK/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells. Biomed Res Int 2013: 580135, 2013.
13. Luo W, Liu Y, Zhang J, Luo X, Lin C and Guo J: Andrographolide inhibits the activation of NFκB and MMP.9 activity in H3255 lung cancer cells. Exp Ther Med 6: 743-746, 2013.
14. Yang M, Huang J, Ma QL, Xu GX and Jin J: Antitumor activity of CDA., a urinary preparation, on human multiple myeloma cell lines via the mitochondrial pathway. Mol Med Rep 9: 1025-1031, 2014.
15. Corso A, Mangiacavalli S, Barbarano L, Montalbetti L, Mazzone A, Fava S, Varettoni M, Zappasodi P, Morra E and Lazzarino M: Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy. Leuk Res 32: 1085-1090, 2008.
16. Yang SH, Wang SM, Syu JP, Chen Y, Wang SD, Peng YS, Kuo MF and Kung HN: Andrographolide induces apoptosis of C6 glioma cells via the ERK.p53.caspase 7.PARP pathway. Biomed Res Int 2014: 312847, 2014.
17. Shen K, Ji L, Lu B, Xu C, Gong C, Morahan G and Wang Z: Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2.MAPKs signaling cascade. Chem Biol Interact 218: 99-106, 2014.
18. Wang Y, He H, Li D, Zhu W, Duan K, Le Y, Liao Y and Ou Y: The role of the TLR4 signaling pathway in cognitive deficits following surgery in aged rats. Mol Med Rep 7: 1137-1142, 2013.
19. Bao H, Lu P, Li Y, Wang L, Li H, He D, Yang Y, Zhao Y, Yang L, Wang M, et al: Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack. Cancer Biol Ther 11: 58-67, 2011.
20. Wang AC, Su QB, Wu FX, Zhang XL and Liu PS: Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur J Clin Invest 39: 157-164, 2009.
21. Huang JM, Zhang GN, Shi Y, Zha X, Zhu Y, Wang MM, Lin Q, Wang W, Lu HY, Ma SQ, Cheng J and Deng BF: Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep 4: 3840, 2014.
22. Klink M, Nowak M, Kielbik M, Bednarska K, Blus E, Szpakowski M, Szyllo K and Sulowska Z: The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro. Cell Stress Chaperones 17: 661-674, 2012.
23. Zhang QQ, Zhou DL, Ding Y, Liu HY, Lei Y, Fang HY, Gu QL, He XD, Qi CL, Yang Y, et al: Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NFκB signaling pathway. Melanoma Res 24: 545-555, 2014.
24. Zhang QQ, Ding Y, Lei Y, Qi CL, He XD, Lan T, Li JC, Gong P, Yang X, Geng JG and Wang LJ: Andrographolide suppress tumor growth by inhibiting TLR4/NFκB signaling activation in insulinoma. Int J Biol Sci 10: 404-414, 2014.
25. Suzuki E, Daniels TR, Helguera G, Penichet ML, Umezawa K and Bonavida B: Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B.cells to cisplatin-induced apoptosis. Int J Oncol 36: 1299-1307, 2010.
26. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA and Standish LJ: A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14: 333-338, 2000.
27. Manni S, Brancalion A, Mandato E, Tubi LQ, Colpo A, Pizzi M, Cappellesso R, Zaffino F, Di Maggio SA, Cabrelle A, et al: Protein kinase CK2 inhibition down modulates the NFκB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. PLoS One 8: e75280, 2013.
28. Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, Chng WJ and Sethi G: Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NFκB regulated gene products in multiple myeloma xenograft mouse model. Oncotarget 5: 634-648, 2014.
29. Wang LJ, Zhou X, Wang W, Tang F, Qi CL, Yang X, Wu S, Lin YQ, Wang JT and Geng JG: Andrographolide inhibits oral squamous cell carcinogenesis through NFκB inactivation. J Dent Res 90: 1246-1252, 2011.